Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shiri Procaccia

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|September 3, 2010
Determination of ERK activity: anti-phospho-ERK antibodies and in vitro phosphorylationShiri Procaccia, Sarah Kraus, Rony Seger
Biochimica Et Biophysica Acta|December 21, 2010
The MAPK cascades: signaling components, nuclear roles and mechanisms of nuclear translocationAlexander Plotnikov, Eldar Zehorai, Shiri Procaccia, et al.
Pain|November 16, 2022
Reply to Montmeat et alJoshua Aviram, Shiri Procaccia, Yelena Vysotski, et al.
Elife|September 11, 2024
Cannabinoid combination targets <i>NOTCH1</i>-mutated T-cell acute lymphoblastic leukemia through the integrated stress response pathwayElazar Besser, Anat Gelfand, Shiri Procaccia, et al.
Scientific Reports|February 23, 2017
Direct binding of MEK1 and MEK2 to AKT induces Foxo1 phosphorylation, cellular migration and metastasisShiri Procaccia, Merav Ordan, Izel Cohen, et al.
Communications Medicine|July 16, 2025
Machine-learning of medical cannabis chemical profiles reveals analgesia beyond placebo expectationsAdi Hatav, Yelena Vysotski, Anna Shapira, et al.
International Journal of Molecular Sciences|December 11, 2025
Development and Characterization of a High-CBD Cannabis Extract Nanoemulsion for Oral Mucosal DeliveryKifah Blal, Georgette Maroukian, Anna Shapira, et al.
Drug Delivery and Translational Research|June 21, 2023
Poly(ethylene glycol)-b-poly(epsilon-caprolactone) nanoparticles as a platform for the improved oral delivery of cannabidiolInbar Shreiber-Livne, Liron Sulimani, Anna Shapira, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 14, 2025
Combination of CBD with minor cannabinoid CBDV suppresses CXCR4 via CB2 receptor and alleviates colitis in miceAnat Gelfand, Elazar Besser, Shiri Procaccia, et al.
Pharmaceuticals (Basel, Switzerland)|October 28, 2023
Evaluating Sex Differences in Efficacy, Safety and Pharmacokinetics in Patients Treated with Cannabis by a Metered-Dose InhalerJoshua Aviram, Marek Glezerman, Eytan Hayam, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Methods in Molecular Biology (Clifton, N.J.)|September 3, 2010
Determination of ERK activity: anti-phospho-ERK antibodies and in vitro phosphorylationShiri Procaccia, Sarah Kraus, Rony Seger
Biochimica Et Biophysica Acta|December 21, 2010
The MAPK cascades: signaling components, nuclear roles and mechanisms of nuclear translocationAlexander Plotnikov, Eldar Zehorai, Shiri Procaccia, et al.
Pain|November 16, 2022
Reply to Montmeat et alJoshua Aviram, Shiri Procaccia, Yelena Vysotski, et al.
Elife|September 11, 2024
Cannabinoid combination targets <i>NOTCH1</i>-mutated T-cell acute lymphoblastic leukemia through the integrated stress response pathwayElazar Besser, Anat Gelfand, Shiri Procaccia, et al.
Scientific Reports|February 23, 2017
Direct binding of MEK1 and MEK2 to AKT induces Foxo1 phosphorylation, cellular migration and metastasisShiri Procaccia, Merav Ordan, Izel Cohen, et al.
Communications Medicine|July 16, 2025
Machine-learning of medical cannabis chemical profiles reveals analgesia beyond placebo expectationsAdi Hatav, Yelena Vysotski, Anna Shapira, et al.
International Journal of Molecular Sciences|December 11, 2025
Development and Characterization of a High-CBD Cannabis Extract Nanoemulsion for Oral Mucosal DeliveryKifah Blal, Georgette Maroukian, Anna Shapira, et al.
Drug Delivery and Translational Research|June 21, 2023
Poly(ethylene glycol)-b-poly(epsilon-caprolactone) nanoparticles as a platform for the improved oral delivery of cannabidiolInbar Shreiber-Livne, Liron Sulimani, Anna Shapira, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 14, 2025
Combination of CBD with minor cannabinoid CBDV suppresses CXCR4 via CB2 receptor and alleviates colitis in miceAnat Gelfand, Elazar Besser, Shiri Procaccia, et al.
Pharmaceuticals (Basel, Switzerland)|October 28, 2023
Evaluating Sex Differences in Efficacy, Safety and Pharmacokinetics in Patients Treated with Cannabis by a Metered-Dose InhalerJoshua Aviram, Marek Glezerman, Eytan Hayam, et al.
Pageof 3